Obstetrics and Gynaecology Forum - Volume 12, Issue 3, 2002
Volume 12, Issue 3, 2002
Author J. MoodleySource: Obstetrics and Gynaecology Forum 12 (2002)More Less
Extracted from text ... EDITORIAL Obstetrics & Gynaecology Forum - August 2002 1 The magpie study all grades of eclampsia, but the severity of pre-eclampsia influenced the frequency of convulsions in that the number of patients needed to treat to prevent one case of eclampsia was 63, 93, and 157 in those women with severe, moderate and mild pre-eclampsia, respectively. These results have important clinical implications for poor countries. There is no doubt that MgS04 should be used for severe cases, its use in moderate and mild cases will depend on the settings in which clinicians work. Each institution needs to take into account, ..
Author Staffan BergstromSource: Obstetrics and Gynaecology Forum 12, pp 4 –5 (2002)More Less
Extracted from text ... Obstetrics & Gynaecology Forum - August 2002 4 Misoprostol for termination of pregnancy Staffan Bergstr?m MD, PhD, Professor and Chair, International Health, Division of International Health (IHCAR), tion an unwanted pregnancy is a failure. On this issue there should be no disagreement. So, there is one common platform for action in all camps in the abortion controversy: from the most hard-line anti-abortion activists to the most accepting and pro-choice activists; all agree that the number of abortions in any setting represents a challenge. The sharp division of conviction lies in the acceptance / refusal of abortion as an asset ..
Author Neil F. MoranSource: Obstetrics and Gynaecology Forum 12, pp 6 –15 (2002)More Less
Extracted from text ... REVIEW ARTICLE Obstetrics & Gynaecology Forum - August 2002 6 The role of microbiological cultures for septic gynaecological admissions Neil F Moran Department of Obstetrics and Gynaecology. Nelson R Mandela School of Medicine. University of Natal, Durban METHODS Data collection. The study was a prospective audit conducted from February to April 1999 at KEH. During the period of the study, data was collected on all patients admitted to the hospital with an admission diagnosis of a septic gynaecological condition. The progress and management of these patients, from the time of admission until either discharge or death, was documented on ..
Source: Obstetrics and Gynaecology Forum 12, pp 16 –21 (2002)More Less
Extracted from text ... REVIEW ARTICLE Obstetrics & Gynaecology Forum - August 2002 16 Safe termination of pregnancy - an enabling ethical and legal framework A Dhai, J Moodley, *M O'Sullivan. MRC/UN Pregnancy Hypertension Research Unit and Department of Obstetrics and Gynaecology, Nelson R Mandela School of Medicine, University of Natal, Durban; *Women's Legal Centre, Cape Town. many times greater than when performed in a medical environment. The WHO estimates that about 75, 000 women die unnecessarily each year after unsafe TOPs. Many more women suffer life-long ill-health and disability, including infertility4. It is important to consider the practice of TOP from the ..
Author H.M. SebitloaneSource: Obstetrics and Gynaecology Forum 12, pp 22 –26 (2002)More Less
Women, especially those in the reproductive age group, make up more than 50% of people living with HIV / AIDS worldwide. Most of these infections are acquired via heterosexual transmission, and therefore the interaction between HIV infection and most of the gynaecological conditions is to be expected. Further research is needed to shed more light into factors that influence the interplay between HIV transmission and genital tract infections and neoplasia, as well as the effect of hormones. Adequate counselling regarding the choice of contraception for the HIV infected woman is important for the individual (especially those living in the developing world where other factors such as poor nutrition may influence the progression of the disease) as well as reduce the incidence of HIV, especially through perinatal transmission.
Source: Obstetrics and Gynaecology Forum 12 (2002)More Less
Extracted from text ... PRODUCT NEWS Obstetrics & Gynaecology Forum - August 2002 28 Early option with mifepristone Indications In South Africa, the MCC has approved the use of Mifegyne? for the following indications: 1. Medical alternative to surgical abortion until the 56th day of amenorrhoea, used in combination with a prostaglandin analogue; 2. Preparation of the cervix for surgical termination of pregnancy; 3. Preparation for the action of a prostaglandin used for termination of pregnancy between 13 and 20 weeks gestation; and 4. For the expulsion of a dead foetus in utero. The Regimen The MCC-approved regimen for early medical abortion includes ..